Search Results Main Content


Start Over

Selection

Healthy Blue Formulary 

Some medications listed may have additional requirements or limitations of coverage. These requirements and limits may include prior authorization, quantity limits, age limits, step therapy or Center for Medicare and Medicaid Services (CMS) coverage requirements.

Medications not listed on the formulary are considered to be non-formulary and are subject to prior authorization.

Additionally, if a medication is available as a generic formulation, this will be Healthy Blue’s preferred agent, unless otherwise noted. If you have any questions about coverage of a certain product, please contact us at 1-866-757-8286.

BlueChoice® HealthPlan is an independent licensee of the Blue Cross and Blue Shield Association. BlueChoice® HealthPlan has contracted with Amerigroup Partnership Plan, LLC, an independent company, for services to support administration of Healthy Connections.

To report fraud, call our confidential Fraud Hotline at 1-877-725-2702. You may also call the South Carolina Department of Health and Human Services Fraud Hotline at 1-888-364-3224 or email fraudres@scdhhs.gov.

Machine Readable Data for Prescription Drug Formulary: Healthy Blue Machine Readable File

Therapeutic Class Search: *antivirals* - drugs for infections/*hepatitis c agent - combinations*** - drugs for viral infections
15 drug(s) found
To view other medications in a therapeutic class, click any class hyperlink in your search results.

Results

Brand Name
Generic Name
Therapeutic Class
Sub-Class
Dose/StrengthStatusNotes & Restrictions
Epclusa Oral Packet 150-37.5 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
PACKET 150-37.5 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Epclusa Oral Packet 200-50 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
PACKET 200-50 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Epclusa Oral Tablet 200-50 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 200-50 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Epclusa Oral Tablet 400-100 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 400-100 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Harvoni Oral Packet 33.75-150 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
PACKET 33.75-150 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Harvoni Oral Packet 45-200 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
PACKET 45-200 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Harvoni Oral Tablet 45-200 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 45-200 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Harvoni Oral Tablet 90-400 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 90-400 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Ledipasvir-Sofosbuvir Oral Tablet 90-400 Mg
Generic Indicator
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 90-400 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Mavyret Oral Packet 50-20 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
PACKET 50-20 MGFormularyQuantity LimitPrior AuthorizationClinical Criteria
Mavyret Oral Tablet 100-40 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 100-40 MGFormularyQuantity LimitPrior AuthorizationClinical Criteria
Sofosbuvir-Velpatasvir Oral Tablet 400-100 Mg
Generic Indicator
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 400-100 MGFormularyQuantity LimitPrior AuthorizationClinical Criteria
Viekira Pak Oral Tablet Therapy Pack 12.5-75-50 &250 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET THERAPY PACK 12.5-75-50 &250 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Vosevi Oral Tablet 400-100-100 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 400-100-100 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria
Zepatier Oral Tablet 50-100 Mg
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
*Antivirals* - Drugs For Infections
*Hepatitis C Agent - Combinations*** - Drugs For Viral Infections
TABLET 50-100 MGNon-PreferredQuantity LimitPrior AuthorizationClinical Criteria

Definition of Status

IconStatusDefinition
FormularyFormulary
Non-PreferredNon-Preferred
Benefit ExclusionBenefit Exclusion

Definition of Restrictions

IconRestrictionDefinition
Age Limit RestrictionAge Limit RestrictionCoverage of this drug may be based on member age.
Clinical CriteriaClinical CriteriaClick on the link for additional coverage details.
Dose OptimizationDose OptimizationNormally involves the conversion from twice-daily dosing to a once-daily dosing schedule.
Dosing LimitDosing LimitThere are limits on the amount of medicine covered within a certain amount of time.
Generic IndicatorGeneric IndicatorGenerics are simply copies of brand-name drugs. Brand-name and generic drugs have the same active ingredients, strength and dose. And the FDA requires that generic drugs meet the same high safety standards for purity, quality, safety and strength.
Medical BenefitMedical BenefitProduct is covered under the Medical Benefit.
Over The CounterOver The CounterOver the counter medication available with a prescription. (Prescribers please indicate OTC on the prescription).
Prescriber NotePrescriber NoteAdditional notes for the prescriber.
Prior AuthorizationPrior AuthorizationPrior authorization is the process of obtaining approval of benefits before certain prescriptions are filled.
Quantity LimitQuantity LimitCertain prescription drugs have specific quantity limits per prescription or per month.
State Carve-OutState Carve-OutThe drug is covered through the Healthy Blue fee-for-service (FFS) program.
Step TherapyStep TherapyYou may need to use one medication before benefits for the use of another medication can be authorized.
©1997-2022 Managed Markets Insight and Technology, LLC. All Rights Reserved | Terms of Use
Formulary Effective Date: 05/16/2022
Updated:
05/2022

Top of Page